RegisterLogin

DC-PGKI

CAT: 804-HY-177944Size: 1 EachDry Ice: NoHazardous: No
1 EachSelected
PRICE
AVAILABILITY
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
DC-PGKI is an orally active ATP-competitive PGK1 inhibitor (IC50 = 0.16 Μm, Kd = 99.08 nM) . DC-PGKI stabilizes PGK1 in vitro and in vivo, and suppresses both glycolytic activity and the kinase function of PGK1. DC-PGKI-mediated inhibition of PGK1 leads to the accumulation of NRF2 (nuclear factor-erythroid factor 2-related factor 2, NFE2L2), which then translocates to the nucleus, binds to the proximal regions of IL-1β and IL-6 genes, and suppresses the LPS-induced expression of these genes. DC-PGKI can be used for the study of colitis[1].
CAS Number
[2829198-49-2]
UNSPSC
12352005
Target
Interleukin Related; Keap1-Nrf2; Phosphoglycerate Kinase (PGK)
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Inflammation/Immunology
Smiles
O=C(N1CCN(C2=NC3=C(N=C2C(OCC)=O)C=C(Cl)C(Cl)=C3)CC1)NC(C=C4)=CC=C4N5CCNCC5
Molecular Formula
C26H29Cl2N7O3
Molecular Weight
558.46
References & Citations
[1]Liao L, et al. A potent PGK1 antagonist reveals PGK1 regulates the production of IL-1β and IL-6. Acta Pharm Sin B. 2022 Nov;12 (11) :4180-4192.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IL-1; IL-6; PGK1

Related Products

CatalogName
HY-160477-01DC-SX029
HY-129427DC-015
HY-147209DC-TEAD3in03
HY-150505-01DC-U4106
HY-119164DC-S238
HY-121093-01DC-S239
HY-43643-01DC-5163
HY-159955DC-159a
HY-12746-01DC-05
HY-147868-01DC-CPin711

Alternative Products

CatalogName
sc-53966DC-SIGN/DC-SIGNR (19F7)
sc-53965DC-SIGN/DC-SIGNR (14E3G7)
2040550/2Both AC And DC Output (DC Unregulated)
sc-74589DC-SIGN/DC-SIGNR (B-2)
2040550/1Both AC And DC Output (DC Unregulated)
5357/50DC 260126
445824-01DC 260126
DI-DR-E12DC Coupler
T70026-01DC-034
T61719-01DC-CPin711

Popular Products